Sign in / Join Now
ETFs & Funds
blue horseshoe (citron) hates
-please sell so he can cover his short position.
have small long position_cheap bio with good product
Finally had time to pick this one apart. More shoes will drop out from overhead compartment, but
think this is very oversold. Not sure if
would go long the equity, but would sell near puts ($15, $16) on ANY further decline. Victim of its own success in ramping up marketing.
Add a reply...
Latest StockTalks »
people get MNK breaking news and analysis by email alert.
Get email alerts on MNK »
Get latest price
From other sites
Extracorporeal Photopheresis (ECP), Including Mallinckrodt's THERAKOS® ECP Immunomodulation, Receives Approval For Reimbursement By Swiss Federal Department Of Home Affairs
at TheStreet (Tue, 8:00AM)
Mallinckrodt To Present At Morgan Stanley Global Healthcare Conference
at TheStreet (Mon, 7:30AM)
Mallinckrodt To Present At Wells Fargo Securities Healthcare Conference
at TheStreet (Fri, 7:30AM)
Mallinckrodt (MNK) to Buy Stratatech for Undisclosed Value
at Zacks.com (Aug 12, 2016)
Mallinckrodt To Acquire Stratatech Corporation, A Regenerative Medicine Company Focused On Proprietary Therapeutic Human Skin Substitute Products
at TheStreet (Aug 10, 2016)